Jee Young Kim Selected Research

Jee Young Kim Research Topics

Disease

7	Neoplasms (Cancer) 06/2021 - 03/2004
2	Ocular Hypertension (Glaucoma, Suspect) 02/2022 - 10/2019
2	Glaucoma 02/2022 - 10/2019
2	Hypertension (High Blood Pressure) 01/2021 - 10/2009
2	Inflammation (Inflammations) 03/2020 - 02/2005
2	Coma (Comas) 11/2015 - 01/2010
2	Heart Arrest (Cardiac Arrest) 11/2015 - 01/2010
2	Wounds and Injuries (Trauma) 10/2013 - 05/2013
1	Fatigue 05/2022
1	Renal Insufficiency (Renal Failure) 01/2021
1	Autolysis 08/2020
1	Atopic Dermatitis (Atopic Eczema) 03/2020
1	Synucleinopathies 04/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Migraine Disorders (Migraine) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Melanosis (Freckles) 06/2016
1	Hemangioma (Angioma) 02/2016
1	Goiter 01/2016
1	Thyroid Diseases (Thyroid Disease) 01/2016
1	Disease Progression 07/2015
1	Myelitis 07/2015
1	Linear IgA Bullous Dermatosis 06/2015
1	Celiac Disease (Celiac Sprue) 06/2015
1	IGA Glomerulonephritis (IGA Nephropathy) 06/2015
1	Infections 06/2015
1	Lentigo (Lentiginosis) 06/2015
1	Liver Abscess 06/2015
1	Purpura 06/2015
1	Skin Diseases (Skin Disease) 06/2015
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2015
1	Warts (Wart) 01/2014
1	Neuroma 01/2014
1	Ischemia 06/2012
1	Epilepsia Partialis Continua 01/2012
1	Alien Limb Phenomenon 01/2012
1	Myasthenia Gravis 12/2011
1	Brain Injuries (Brain Injury) 01/2010
1	Lymphatic Metastasis 03/2009
1	Papillary Thyroid Cancer 03/2009
1	Neoplasm Metastasis (Metastasis) 03/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2008

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 04/2016 - 06/2015
2	CollagenIBA 10/2013 - 05/2013
2	Particulate MatterIBA 10/2009 - 02/2005
1	Latanoprost (Xalatan)FDA Link 02/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 02/2022
1	Purinergic P1 Receptor AntagonistsIBA 02/2022
1	FructoseIBA 01/2021
1	SaltsIBA 01/2021
1	Melanins (Melanin)IBA 08/2020
1	SesquiterpenesIBA 03/2020
1	LactonesIBA 03/2020
1	AntioxidantsIBA 03/2020
1	EnzymesIBA 03/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2020
1	Retinaldehyde (Retinal)IBA 10/2019
1	Ethanol (Ethyl Alcohol)IBA 10/2019
1	SynucleinsIBA 04/2019
1	Proteins (Proteins, Gene)FDA Link 04/2019
1	Biomarkers (Surrogate Marker)IBA 04/2019
1	alpha-SynucleinIBA 04/2019
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2019
1	1- myristoyl- 2- (12- ((5- dimethylamino- 1- naphthalenesulfonyl)amino)dodecanoyl)- sn- glycero- 3- phosphocholineIBA 01/2019
1	CopperIBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2017
1	A-factor (Streptomyces)IBA 04/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Carbamazepine (Tegretol)FDA LinkGeneric 06/2015
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 06/2015
1	Immunoglobulin A (IgA)IBA 06/2015
1	Metronidazole (Metric)FDA LinkGeneric 06/2015
1	Vancomycin FDA LinkGeneric 06/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2015
1	Sodium Tetradecyl Sulfate (Sotradecol)FDA Link 01/2015
1	Ointments (Pastes)IBA 10/2013
1	Tacrolimus (Prograf)FDA LinkGeneric 05/2013
1	SteroidsIBA 05/2013
1	MicroRNAs (MicroRNA)IBA 06/2012
1	Transforming Growth Factor-beta Type II ReceptorIBA 06/2012
1	erucylphosphocholineIBA 01/2012

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2017
2	Lasers (Laser) 06/2016 - 06/2015
1	Medication Errors (Medication Error) 05/2022
1	Nephrectomy 06/2021
1	Endovascular Procedures 01/2021
1	Microspheres (Microsphere) 10/2019
1	Art Therapy 01/2018
1	Solid-State Lasers 06/2016
1	Laryngoscopes 02/2016
1	Induced Hypothermia 11/2015
1	Immunotherapy 07/2015
1	Laser Therapy (Surgery, Laser) 01/2014
1	Transplantation 06/2012
1	Critical Care (Surgical Intensive Care) 12/2011
1	Resuscitation 01/2010
1	Thyroidectomy 03/2009
1	Lymph Node Excision (Lymph Node Dissection) 03/2009